Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 132 for Epilepsy

Edit search filters
  1. A Study to Evaluate MR-guided Focused Ultrasound Ablation Therapy to Treat Focal Epilepsy.

    Rochester, MN

  2. A Study to assess the Safety of NRL-1 for the Treatment of People with Epilepsy

    Rochester, MN

  3. Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients with Medically Refractory Partial Epilepsy

    Jacksonville, FL, Rochester, MN

  4. A Study to Evaluate fMRI of Active Deep Brain Stimulation in Epilepsy

    Jacksonville, FL

  5. A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy, with an Open-Label Extension

    Jacksonville, FL

  6. A Study of the Use of Smartphone Videos to Aid in Evaluation of Epileptic Seizures

    Jacksonville, FL, Scottsdale/Phoenix, AZ, Rochester, MN

  7. A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

    Rochester, MN

  8. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

    Scottsdale/Phoenix, AZ

  9. An Open-label Extension Trial of the Effectiveness and Safety of CVL-865 to Treat Focal Onset Seizures.

    Jacksonville, FL

  10. Usage of EpiFinder Clinical Decision Support in the Assessment of Epilepsy Cases at Mayo Clinic Hospital in AZ

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer